Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Inhibition With GP IIb/IIIa Inhibitor in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). A Compassionate Use Protocol

NCT04368377 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT04368377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04368377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Inhibition With GP IIb/IIIa Inhibitor in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). A Compassionate Use Protocol
Lead sponsor
University of Milan
Phase
Phase 2
Overall status
Completed
Start date
April 6, 2020
Completion date
April 23, 2020
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, embolism and thrombosis, pneumonia, viral, respiratory failure